A pharmacist in Sidney, Nebraska, argues that government policy fails to recognize distinct medical conditions when regulating orphan-designated drugs. The pharmacy owner notes that while Crohn's disease and juvenile idiopathic arthritis are separate conditions, current regulations do not reflect this distinction. Patients at the specialty pharmacy travel long distances across the Nebraska prairie to receive medications such as Rinvoq in person. This approach allows individuals with conditions like Crohn's disease to bypass remote mail-order services and consult directly with their pharmacist.